OctoPlus N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 22 sep 2010 - 07:26

Statutaire naam OctoPlus N.V.

Titel OctoPlus wins drug manufacturing contract from French-based company

Bericht OctoPlus N.V. (“OctoPlus” or the “Company”) (Euronext: OCTO), announces today that it has signed a pharmaceutical manufacturing contract with an existing client, a French-based biotechnology company. The undisclosed contract value will make a material contribution to OctoPlus’ annual revenues. Under the contract terms, OctoPlus will perform clinical manufacturing for the client’s product candidate.

Vorige register resultaat

Volgende register resultaat

Gerelateerde downloads

201009220000000001_OctoPlus wins drug manufacturing contract from French-based biotechnology company.pdf (opens in a new window)

Datum laatste update: 01 september 2024